Skip to main content
UV Germi logo

UV Germi — Investor Relations & Filings

Ticker · ALUVI ISIN · FR0011898584 LEI · 969500B6HIQ3B0JLR552 PA Manufacturing
Filings indexed 126 across all filing types
Latest filing 2026-04-23 Earnings Release
Country FR France
Listing PA ALUVI

UV Germi specializes in the design, manufacturing, and marketing of equipment based on ultraviolet (UV) technology. The company develops solutions for the chemical-free disinfection, purification, and depollution of water, air, and surfaces. Its product range includes UV reactors and treatment units for various applications, such as drinking water purification, wastewater treatment, and air and surface sanitation. A key area of expertise is the dechloramination of water in public swimming pools. UV Germi focuses on continuous research and development to create innovative and environmentally sensitive purification systems.

Recent filings

Filing Released Lang Actions
UV GERMI : RÉSULTATS ANNUELS 2025
Earnings Release Classification · 1% confidence The document is a press release (“Communiqué de presse”) summarising the full-year 2025 financial results with key highlights (EBE, margin, net result, outlook) and a results table. It is not the full Annual Report (10-K) nor merely an announcement of its publication, but the initial earnings release of annual results. Therefore it fits the Earnings Release category. FY 2025
2026-04-23 French
UV GERMI : RESULTATS ANNUELS 2025
Earnings Release Classification · 1% confidence The document is a press communiqué announcing UV GERMI’s full‐year 2025 financial performance, including key metrics (revenues, EBE, margins, net result) and outlook for 2026. It is not the full annual report but rather the initial public announcement of annual results. This matches the definition of an Earnings Release (ER). FY 2025
2026-04-23 French
UV GERMI: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Regulatory Filings Classification · 1% confidence The document is a monthly disclosure of the total number of voting rights and shares composing the share capital, as required by Article 223-16 of the AMF General Regulation. This type of regulatory disclosure regarding share capital structure and voting rights does not fit into specific categories like 'Major Shareholding Notification' (which concerns individual investors) or 'Share Issue' (which concerns specific capital changes). Therefore, it falls under the general regulatory filing category.
2026-03-11 French
UV GERMI: Information mensuelle relative au nombre total des droits de vote et dactions composant le capital social
Regulatory Filings Classification · 1% confidence The document is a monthly regulatory disclosure from UV GERMI regarding the total number of voting rights and shares composing the share capital, as required by Article 223-16 of the AMF General Regulation. This type of filing is a standard regulatory requirement for French listed companies to update the market on capital structure changes. Since it does not fit into specific categories like 'Share Issue' (which would imply a new issuance event) or 'Major Shareholding' (which would be a notification of a specific investor's stake), it falls under the general regulatory filing category.
2026-03-11 French
UV GERMI: Résultat de l’offre publique de rachat d’actions initiée par UV GERMI sur ses propres actions - erratum
Transaction in Own Shares Classification · 1% confidence The document is a press release detailing the results of a public share buyback offer (OPRA) initiated by UV GERMI. It specifies the number of shares repurchased, the price, the settlement date, and the subsequent impact on the company's capital structure. Since the document reports on the company buying back its own shares, it falls under the 'Transaction in Own Shares' category.
2026-03-04 French
UV GERMI: Resultat de loffre publique de rachat dactions initiee par UV GERMI sur ses propres actions - erratum
Transaction in Own Shares Classification · 1% confidence The document is an official announcement regarding the results of a public share buyback offer (OPRA) initiated by UV GERMI. It details the number of shares repurchased, the price, the cancellation of shares, and the resulting impact on capital structure. This falls directly under the definition of 'Transaction in Own Shares' (POS), as it reports the company buying back its own shares.
2026-03-04 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.